{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T15:37:37Z","timestamp":1774366657579,"version":"3.50.1"},"reference-count":66,"publisher":"Bentham Science Publishers Ltd.","issue":"22","funder":[{"DOI":"10.13039\/501100009432","name":"Government of Russian Federation","doi-asserted-by":"publisher","award":["08-08"],"award-info":[{"award-number":["08-08"]}],"id":[{"id":"10.13039\/501100009432","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2020,6,30]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Omic-technologies (genomics, transcriptomics, proteomics and metabolomics)\nhave become more important in current medical science. Among them, it is metabolomics that\nmost accurately reflects the minor changes in body functioning, as it focuses on metabolome \u2013\nthe group of the metabolism products, both intermediate and end. Therefore, metabolomics is\nactively engaged in fundamental and clinical studies and search for potential biomarkers. The\nbiomarker could be used in diagnostics, management and stratification of the patients, as well\nas in prognosing the outcomes. The good example is gynecology, since many gynecological\ndiseases lack effective biomarkers. In the current review, we aimed to summarize the results\nof the studies, devoted to the search of potential metabolomic biomarkers for the most common\ngynecological diseases.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867326666190104124245","type":"journal-article","created":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T08:01:56Z","timestamp":1546588916000},"page":"3611-3622","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Metabolomic Biomarkers in Gynecology: A Treasure Path or a False Path?"],"prefix":"10.2174","volume":"27","author":[{"given":"Igor","family":"Govorov","sequence":"first","affiliation":[{"name":"International Research Centre \u201cBiotechnologies of the Third Millennium\u201d, ITMO University, Saint-Petersburg 197341, Russian Federation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanislav","family":"Sitkin","sequence":"additional","affiliation":[{"name":"International Research Centre \u201cBiotechnologies of the Third Millennium\u201d, ITMO University, Saint-Petersburg 197341, Russian Federation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatyana","family":"Pervunina","sequence":"additional","affiliation":[{"name":"International Research Centre \u201cBiotechnologies of the Third Millennium\u201d, ITMO University, Saint-Petersburg 197341, Russian Federation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexey","family":"Moskvin","sequence":"additional","affiliation":[{"name":"International Research Centre \u201cBiotechnologies of the Third Millennium\u201d, ITMO University, Saint-Petersburg 197341, Russian Federation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Baranenko","sequence":"additional","affiliation":[{"name":"International Research Centre \u201cBiotechnologies of the Third Millennium\u201d, ITMO University, Saint-Petersburg 197341, Russian Federation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduard","family":"Komlichenko","sequence":"additional","affiliation":[{"name":"International Research Centre \u201cBiotechnologies of the Third Millennium\u201d, ITMO University, Saint-Petersburg 197341, Russian Federation"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"Bray F.","year":"2018","unstructured":"Bray F.; Ferlay J.; Soerjomataram I.; Siegel R.L.; Torre L.A.; Jemal A.; Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018,68(6),394-424","journal-title":"CA Cancer J Clin"},{"key":"ref=2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp471","author":"Arbyn M.","year":"2010","unstructured":"Arbyn M.; Anttila A.; Jordan J.; Ronco G.; Schenck U.; Segnan N.; Wiener H.; Herbert A.; von Karsa L.;  Ann Oncol, 21(3), 448-4582010","journal-title":"Ann Oncol,"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"5485","DOI":"10.1007\/s13277-015-4164-x","volume":"37","author":"Yin M.Z.","year":"2016","unstructured":"Yin M.Z.; Tan S.; Li X.; Hou Y.; Cao G.; Li K.; Kou J.; Lou G.; Identification of phosphatidylcholine and lysophosphatidylcholine as novel biomarkers for cervical cancers in a prospective cohort study. Tumour Biol 2016,37(4),5485-5492","journal-title":"Tumour Biol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"43353","DOI":"10.1038\/srep43353","volume":"7","author":"Yang K.","year":"2017","unstructured":"Yang K.; Xia B.; Wang W.; Cheng J.; Yin M.; Xie H.; Li J.; Ma L.; Yang C.; Li A.; Fan X.; Dhillon H.S.; Hou Y.; Lou G.; Li K.; A comprehensive analysis of metabolomics and transcriptomics in cervical cancer. Sci Rep 2017,7,43353","journal-title":"Sci Rep"},{"key":"ref=5","first-page":"174","volume":"36","author":"Ye N.","year":"2015","unstructured":"Ye N.; Liu C.; Shi P.; Metabolomics analysis of cervical cancer, cervical intraepithelial neoplasia and chronic cervicitis by 1H NMR spectroscopy. Eur J Gynaecol Oncol 2015,36(2),174-180","journal-title":"Eur J Gynaecol Oncol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3892\/etm.2012.509","volume":"3","author":"Hasim A.","year":"2012","unstructured":"Hasim A.; Ali M.; Mamtimin B.; Ma J.Q.; Li Q.Z.; Abudula A.; Metabonomic signature analysis of cervical carcinoma and precancerous lesions in women by (1)H NMR spectroscopy. Exp Ther Med 2012,3(6),945-951","journal-title":"Exp Ther Med"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/sj.bjc.6604972","volume":"100","author":"Mu\u00f1oz N.","year":"2009","unstructured":"Mu\u00f1oz N.; Hernandez-Suarez G.; M\u00e9ndez F.; Molano M.; Posso H.; Moreno V.; Murillo R.; Ronderos M.; Meijer C.; Mu\u00f1oz A.; Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women. Br J Cancer Instituto Nacional de Cancerolog\u00eda HPV Study Group2009,100(7),1184-1190","journal-title":"Br J Cancer"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"601","DOI":"10.4155\/bio-2017-0012","volume":"9","author":"Walker H.","year":"2017","unstructured":"Walker H.; Burrell M.; Flatley J.; Powers H.; A metabolite profiling method for diagnosis of precancerous cervical lesions and HPV persistence. Bioanalysis 2017,9(8),601-608","journal-title":"Bioanalysis"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1039\/C4MB00054D","volume":"10","author":"Hou Y.","year":"2014","unstructured":"Hou Y.; Yin M.; Sun F.; Zhang T.; Zhou X.; Li H.; Zheng J.; Chen X.; Li C.; Ning X.; Lou G.; Li K.; A metabolomics approach for predicting the response to neoadjuvant chemotherapy in cervical cancer patients. Mol Biosyst 2014,10(8),2126-2133","journal-title":"Mol Biosyst"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.radonc.2015.07.037","volume":"117","author":"Chai Y.","year":"2015","unstructured":"Chai Y.; Wang J.; Wang T.; Yang Y.; Su J.; Shi F.; Wang J.; Zhou X.; He B.; Ma H.; Liu Z.; Application of 1H NMR spectroscopy-based metabonomics to feces of cervical cancer patients with radiation-induced acute intestinal symptoms. Radiother Oncol 2015,117(2),294-301","journal-title":"Radiother Oncol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.1039\/C4AY00399C","volume":"6","author":"Liang Q.","year":"2014","unstructured":"Liang Q.; Yu Q.; Wu H.; Zhu Y-Z.; Zhang A-H.; Metabolite fingerprint analysis of cervical cancer using LC-QTOF\/MS and multivariate data analysis. Anal Methods 2014,6(12),3937-3942","journal-title":"Anal Methods"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3109\/0284186X.2011.648338","volume":"51","author":"Fan L.","year":"2012","unstructured":"Fan L.; Zhang W.; Yin M.; Zhang T.; Wu X.; Zhang H.; Sun M.; Li Z.; Hou Y.; Zhou X.; Lou G.; Li K.; Identification of metabolic biomarkers to diagnose epithelial ovarian cancer using a UPLC\/QTOF\/MS platform. Acta Oncol 2012,51(4),473-479","journal-title":"Acta Oncol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"883","DOI":"10.4143\/crt.2017.275","volume":"50","author":"Lee J.H.","year":"2018","unstructured":"Lee J.H.; Kim Y.H.; Kim K-H.; Cho J.Y.; Woo S.M.; Yoo B.C.; Kim S.C.; Profiling of serum metabolites using MALDI-TOF and Triple-TOF mass spectrometry to develop a screen for ovarian cancer. Cancer Res Treat 2018,50(3),883-893","journal-title":"Cancer Res Treat"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"5835","DOI":"10.1158\/1078-0432.CCR-10-1434","volume":"16","author":"Slupsky C.M.","year":"2010","unstructured":"Slupsky C.M.; Steed H.; Wells T.H.; Dabbs K.; Schepansky A.; Capstick V.; Faught W.; Sawyer M.B.; Urine metabolite analysis offers potential early diagnosis of ovarian and breast cancers. Clin Cancer Res 2010,16(23),5835-5841","journal-title":"Clin Cancer Res"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1021\/pr3009572","volume":"12","author":"Zhang T.","year":"2013","unstructured":"Zhang T.; Wu X.; Ke C.; Yin M.; Li Z.; Fan L.; Zhang W.; Zhang H.; Zhao F.; Zhou X.; Lou G.; Li K.; Identification of potential biomarkers for ovarian cancer by urinary metabolomic profiling. J Proteome Res 2013,12(1),505-512","journal-title":"J Proteome Res"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1080\/14737140.2017.1398088","volume":"17","author":"Corrado G.","year":"2017","unstructured":"Corrado G.; Salutari V.; Palluzzi E.; Distefano M.G.; Scambia G.; Ferrandina G.; Optimizing treatment in recurrent epithelial ovarian cancer. Expert Rev Anticancer Ther 2017,17(12),1147-1158","journal-title":"Expert Rev Anticancer Ther"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s11306-016-0990-0","volume":"12","author":"Turkoglu O.","year":"2016","unstructured":"Turkoglu O.; Zeb A.; Graham S.; Szyperski T.; Szender J.B.; Odunsi K.; Bahado-Singh R.; Metabolomics of biomarker discovery in ovarian cancer: a systematic review of the current literature. Metabolomics 2016,12(4),60","journal-title":"Metabolomics"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.7150\/jca.15074","volume":"7","author":"Fan L.","year":"2016","unstructured":"Fan L.; Yin M.; Ke C.; Ge T.; Zhang G.; Zhang W.; Zhou X.; Lou G.; Li K.; Use of plasma metabolomics to identify diagnostic biomarkers for early stage epithelial ovarian cancer. J Cancer 2016,7(10),1265-1272","journal-title":"J Cancer"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"32134","DOI":"10.18632\/oncotarget.16739","volume":"8","author":"Xie H.","year":"2017","unstructured":"Xie H.; Hou Y.; Cheng J.; Openkova M.S.; Xia B.; Wang W.; Li A.; Yang K.; Li J.; Xu H.; Yang C.; Ma L.; Li Z.; Fan X.; Li K.; Lou G.; Metabolic profiling and novel plasma biomarkers for predicting survival in epithelial ovarian cancer. Oncotarget 2017,8(19),32134-32146","journal-title":"Oncotarget"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1039\/C4MB00407H","volume":"11","author":"Zhang H.","year":"2015","unstructured":"Zhang H.; Ge T.; Cui X.; Hou Y.; Ke C.; Yang M.; Yang K.; Wang J.; Guo B.; Zhang F.; Lou G.; Li K.; Prediction of advanced ovarian cancer recurrence by plasma metabolic profiling. Mol Biosyst 2015,11(2),516-521","journal-title":"Mol Biosyst"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1021\/pr101050d","volume":"10","author":"Garcia E.","year":"2011","unstructured":"Garcia E.; Andrews C.; Hua J.; Kim H.L.; Sukumaran D.K.; Szyperski T.; Odunsi K.; Diagnosis of early stage ovarian cancer by 1H NMR metabonomics of serum explored by use of a microflow NMR probe. J Proteome Res 2011,10(4),1765-1771","journal-title":"J Proteome Res"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1158\/0008-5472.CAN-15-2298","volume":"76","author":"Hilvo M.","year":"2016","unstructured":"Hilvo M.; de Santiago I.; Gopalacharyulu P.; Schmitt W.D.; Budczies J.; Kuhberg M.; Dietel M.; Aittokallio T.; Markowetz F.; Denkert C.; Sehouli J.; Frezza C.; Darb-Esfahani S.; Braicu E.I.; Accumulated metabolites of hydroxybutyric acid serve as diagnostic and prognostic biomarkers of ovarian high-grade serous carcinomas. Cancer Res 2016,76(4),796-804","journal-title":"Cancer Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/ijc.29010","volume":"136","author":"Ke C.","year":"2015","unstructured":"Ke C.; Hou Y.; Zhang H.; Fan L.; Ge T.; Guo B.; Zhang F.; Yang K.; Wang J.; Lou G.; Li K.; Large-scale profiling of metabolic dysregulation in ovarian cancer. Int J Cancer 2015,136(3),516-526","journal-title":"Int J Cancer"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1021\/acs.jproteome.5b00307","volume":"14","author":"Selen E.S.","year":"2015","unstructured":"Selen E.S.; Bolandnazar Z.; Tonelli M.; B\u00fctz D.E.; Haviland J.A.; Porter W.P.; Assadi-Porter F.M.; Assadi-Porter, F.M. NMR metabolomics show evidence for mitochondrial oxidative stress in a mouse model of polycystic ovary syndrome. J Proteome Res 2015,14(8),3284-3291","journal-title":"J Proteome Res"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/s41591-018-0035-5","volume":"24","author":"Tata B.","year":"2018","unstructured":"Tata B.; Mimouni N.E.H.; Barbotin A-L.; Malone S.A.; Loyens A.; Pigny P.; Dewailly D.; Catteau-Jonard S.; Sundstr\u00f6m-Poromaa I.; Piltonen T.T.; Dal Bello F.; Medana C.; Prevot V.; Clasadonte J.; Giacobini P.; Elevated prenatal anti-M\u00fcllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood. Nat Med 2018,24(6),834-846","journal-title":"Nat Med"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/S1472-6483(10)61187-X","volume":"12","author":"Balaban B.","year":"2006","unstructured":"Balaban B.; Urman B.; Effect of oocyte morphology on embryo development and implantation. Reprod Biomed Online 2006,12(5),608-615","journal-title":"Reprod Biomed Online"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.mehy.2012.01.009","volume":"78","author":"Arya B.K.","year":"2012","unstructured":"Arya B.K.; Haq A.U.; Chaudhury K.; Oocyte quality reflected by follicular fluid analysis in poly cystic ovary syndrome (PCOS): a hypothesis based on intermediates of energy metabolism. Med Hypotheses 2012,78(4),475-478","journal-title":"Med Hypotheses"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ejogrb.2011.11.005","volume":"160","author":"Galazis N.","year":"2012","unstructured":"Galazis N.; Iacovou C.; Haoula Z.; Atiomo W.; Metabolomic biomarkers of impaired glucose tolerance and type 2 diabetes mellitus with a potential for risk stratification in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2012,160(2),121-130","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1741-7015-10-153","volume":"10","author":"Zhao Y.","year":"2012","unstructured":"Zhao Y.; Fu L.; Li R.; Wang L.N.; Yang Y.; Liu N.N.; Zhang C.M.; Wang Y.; Liu P.; Tu B.B.; Zhang X.; Qiao J.; Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis. BMC Med 2012,10,153","journal-title":"BMC Med"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1021\/pr3000317","volume":"11","author":"Sun L.","year":"2012","unstructured":"Sun L.; Hu W.; Liu Q.; Hao Q.; Sun B.; Zhang Q.; Mao S.; Qiao J.; Yan X.; Metabonomics reveals plasma metabolic changes and inflammatory marker in polycystic ovary syndrome patients. J Proteome Res 2012,11(5),2937-2946","journal-title":"J Proteome Res"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1093\/molehr\/gas029","volume":"18","author":"Atiomo W.","year":"2012","unstructured":"Atiomo W.; Daykin C.A.; Metabolomic biomarkers in women with polycystic ovary syndrome: a pilot study. Mol Hum Reprod 2012,18(11),546-553","journal-title":"Mol Hum Reprod"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1021\/pr401130w","volume":"13","author":"Zhao X.","year":"2014","unstructured":"Zhao X.; Xu F.; Qi B.; Hao S.; Li Y.; Li Y.; Zou L.; Lu C.; Xu G.; Hou L.; Serum metabolomics study of polycystic ovary syndrome based on liquid chromatography-mass spectrometry. J Proteome Res 2014,13(2),1101-1111","journal-title":"J Proteome Res"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"4683","DOI":"10.1007\/s00216-015-8670-x","volume":"407","author":"Dong F.","year":"2015","unstructured":"Dong F.; Deng D.; Chen H.; Cheng W.; Li Q.; Luo R.; Ding S.; Serum metabolomics study of polycystic ovary syndrome based on UPLC-QTOF-MS coupled with a pattern recognition approach. Anal Bioanal Chem 2015,407(16),4683-4695","journal-title":"Anal Bioanal Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cca.2015.06.008","volume":"448","author":"Wang W.","year":"2015","unstructured":"Wang W.; Wang S.; Tan S.; Wen M.; Qian Y.; Zeng X.; Guo Y.; Yu C.; Detection of urine metabolites in polycystic ovary syndrome by UPLC triple-TOF-MS. Clin Chim Acta 2015,448,39-47","journal-title":"Clin Chim Acta"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jpba.2016.01.025","volume":"121","author":"Chen Y.X.","year":"2016","unstructured":"Chen Y.X.; Zhang X.J.; Huang J.; Zhou S.J.; Liu F.; Jiang L.L.; Chen M.; Wan J.B.; Yang D.Z.; UHPLC\/Q-TOFMS-based plasma metabolomics of polycystic ovary syndrome patients with and without insulin resistance. J Pharm Biomed Anal 2016,121,141-150","journal-title":"J Pharm Biomed Anal"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1039\/C6MB00420B","volume":"12","author":"RoyChoudhury S.","year":"2016","unstructured":"RoyChoudhury S.; Mishra B.P.; Khan T.; Chattopadhayay R.; Lodh I.; Datta Ray C.; Bose G.; Sarkar H.S.; Srivastava S.; Joshi M.V.; Chakravarty B.; Chaudhury K.; Serum metabolomics of Indian women with polycystic ovary syndrome using H NMR coupled with a pattern recognition approach. Mol Biosyst 2016,12(11),3407-3416","journal-title":"Mol Biosyst"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.metabol.2017.03.002","volume":"71","author":"Chang A.Y.","year":"2017","unstructured":"Chang A.Y.; Lalia A.Z.; Jenkins G.D.; Dutta T.; Carter R.E.; Singh R.J.; Nair K.S.; Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome. Metabolism 2017,71,52-63","journal-title":"Metabolism"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.plefa.2017.09.001","volume":"126","author":"Szczuko M.","year":"2017","unstructured":"Szczuko M.; Zapa\u0142owska-Chwy\u0107 M.; Drozd A.; Maciejewska D.; Starczewski A.; Stachowska E.; Metabolic pathways of oleic and palmitic acid are intensified in PCOS patients with normal androgen levels. Prostaglandins Leukot Essent Fatty Acids 2017,126,105-111","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s11306-017-1253-4","volume":"13","year":"2017","unstructured":"S.; More, T.H.; Chattopadhyay, R Lodh, I.; Ray, C.D.; Bose, G.; Sarkar, H.S.; Chakravarty, B.; Rapole, S.; Chaudhury, K. Polycystic ovary syndrome in Indian women: a mass spectrometry based serum metabolomics approach. Metabolomics RoyChoudhury2017,13(10),115","journal-title":"Metabolomics"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.mce.2013.02.009","volume":"370","author":"Insenser M.","year":"2013","unstructured":"Insenser M.; Montes-Nieto R.; Murri M.; Escobar-Morreale H.F.; Proteomic and metabolomic approaches to the study of polycystic ovary syndrome. Mol Cell Endocrinol 2013,370(1-2),65-77","journal-title":"Mol Cell Endocrinol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cca.2013.12.018","volume":"429","author":"Murri M.","year":"2014","unstructured":"Murri M.; Insenser M.; Escobar-Morreale H.F.; Metabolomics in polycystic ovary syndrome. Clin Chim Acta 2014,429,181-188","journal-title":"Clin Chim Acta"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.fertnstert.2012.05.031","volume":"98","author":"Medicine P.C.A.S.R.","year":"2012","unstructured":"Medicine P.C.A.S.R.; Endometriosis and infertility: a committee opinion. Fertil Steril Practice Committee of the American Society for Reproductive Medicine2012,98(3),591-598","journal-title":"Fertil Steril"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.fertnstert.2008.04.056","volume":"92","author":"Meuleman C.","year":"2009","unstructured":"Meuleman C.; Vandenabeele B.; Fieuws S.; Spiessens C.; Timmerman D.; D\u2019Hooghe T.; High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners. Fertil Steril 2009,92(1),68-74","journal-title":"Fertil Steril"},{"key":"ref=44","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/7265238","volume":"2017","author":"Scutiero G.","year":"2017","unstructured":"Scutiero G.; Iannone P.; Bernardi G.; Bonaccorsi G.; Spadaro S.; Volta C.A.; Greco P.; Nappi L.; Oxidative stress and endometriosis: a systematic review of the literature. Oxid Med Cell Longev 2017,2017","journal-title":"Oxid Med Cell Longev"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1093\/humrep\/des152","volume":"27","author":"Vouk K.","year":"2012","unstructured":"Vouk K.; Hevir N.; Ribi\u0107-Pucelj M.; Haarpaintner G.; Scherb H.; Osredkar J.; M\u00f6ller G.; Prehn C.; Ri\u017ener T.L.; Adamski J.; Discovery of phosphatidylcholines and sphingomyelins as biomarkers for ovarian endometriosis. Hum Reprod 2012,27(10),2955-2965","journal-title":"Hum Reprod"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/mas.21484","volume":"36","author":"Yang H.","year":"2017","unstructured":"Yang H.; Lau W.B.; Lau B.; Xuan Y.; Zhou S.; Zhao L.; Luo Z.; Lin Q.; Ren N.; Zhao X.; Wei Y.; A mass spectrometric insight into the origins of benign gynecological disorders. Mass Spectrom Rev 2017,36(3),450-470","journal-title":"Mass Spectrom Rev"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1093\/humrep\/deq141","volume":"25","author":"Somigliana E.","year":"2010","unstructured":"Somigliana E.; Vercellini P.; Vigano\u2019 P.; Benaglia L.; Crosignani P.G.; Fedele L.; Non-invasive diagnosis of endometriosis: the goal or own goal? Hum Reprod 2010,25(8),1863-1868","journal-title":"Hum Reprod"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/S0015-0282(98)00355-0","volume":"70","author":"Mol B.W.","year":"1998","unstructured":"Mol B.W.; Bayram N.; Lijmer J.G.; Wiegerinck M.A.; Bongers M.Y.; van der Veen F.; Bossuyt P.M.; The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis. Fertil Steril 1998,70(6),1101-1108","journal-title":"Fertil Steril"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/GRF.0b013e3181db7bde","volume":"53","author":"McLeod B.S.","year":"2010","unstructured":"McLeod B.S.; Retzloff M.G.; Epidemiology of endometriosis: an assessment of risk factors. Clin Obstet Gynecol 2010,53(2),389-396","journal-title":"Clin Obstet Gynecol"},{"key":"ref=50","first-page":"345","volume":"15","author":"Draj H.A.","year":"2017","unstructured":"Draj H.A.; Abbas A.A.; Abdullah T.H.; Serum levels of glycodelin a and soluble intracellular adhesion molecule-1 as biomarkers for endometriosis. Iraqi JMS 2017,15(4),345-349","journal-title":"Iraqi JMS"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"711","DOI":"10.2147\/IJWH.S141021","volume":"9","author":"Ekarattanawong S.","year":"2017","unstructured":"Ekarattanawong S.; Tanprasertkul C.; Somprasit C.; Chamod P.; Tiengtip R.; Bhamarapravatana K.; Suwannarurk K.; Possibility of using superoxide dismutase and glutathione peroxidase as endometriosis biomarkers. Int J Womens Health 2017,9,711-716","journal-title":"Int J Womens Health"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1055\/s-0037-1601398","volume":"39","author":"Reis F.M.","year":"2017","unstructured":"Reis F.M.; Monteiro C.S.; Carneiro M.M.; Biomarkers of pelvic endometriosis. Rev Bras Ginecol Obstet 2017,39(3),91-93","journal-title":"Rev Bras Ginecol Obstet"},{"key":"ref=53","doi-asserted-by":"publisher","DOI":"10.1111\/aji.12794","volume":"79","author":"Trapero C.","year":"2018","unstructured":"Trapero C.; Jover L.; Fern\u00e1ndez-Montol\u00ed M.E.; Garc\u00eda-Tejedor A.; Vidal A.; G\u00f3mez de Aranda I.; Ponce J.; Matias-Guiu X.; Mart\u00edn-Satu\u00e9 M.; Analysis of the ectoenzymes ADA, ALP, ENPP1, and ENPP3, in the contents of ovarian endometriomas as candidate biomarkers of endometriosis. Am J Reprod Immunol 2018,79(2)","journal-title":"Am J Reprod Immunol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1039\/c2mb25353d","volume":"8","author":"Dutta M.","year":"2012","unstructured":"Dutta M.; Joshi M.; Srivastava S.; Lodh I.; Chakravarty B.; Chaudhury K.; A metabonomics approach as a means for identification of potential biomarkers for early diagnosis of endometriosis. Mol Biosyst 2012,8(12),3281-3287","journal-title":"Mol Biosyst"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1093\/ajcn\/81.5.1142","volume":"81","author":"Vissers Y.L.","year":"2005","unstructured":"Vissers Y.L.; Dejong C.H.; Luiking Y.C.; Fearon K.C.; von Meyenfeldt M.F.; Deutz N.E.; Plasma arginine concentrations are reduced in cancer patients: evidence for arginine deficiency? Am J Clin Nutr 2005,81(5),1142-1146","journal-title":"Am J Clin Nutr"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1093\/humrep\/des234","volume":"27","author":"Vodolazkaia A.","year":"2012","unstructured":"Vodolazkaia A.; El-Aalamat Y.; Popovic D.; Mihalyi A.; Bossuyt X.; Kyama C.M.; Fassbender A.; Bokor A.; Schols D.; Huskens D.; Meuleman C.; Peeraer K.; Tomassetti C.; Gevaert O.; Waelkens E.; Kasran A.; De Moor B.; D\u2019Hooghe T.M.; Evaluation of a panel of 28 biomarkers for the non-invasive diagnosis of endometriosis. Hum Reprod 2012,27(9),2698-2711","journal-title":"Hum Reprod"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.29252\/ijrm.14.1.1","volume":"14","author":"Ghazi N.","year":"2016","unstructured":"Ghazi N.; Arjmand M.; Akbari Z.; Mellati A.O.; Saheb-Kashaf H.; Zamani Z.; (1)H NMR- based metabolomics approaches as non- invasive tools for diagnosis of endometriosis. Int J Reprod Biomed (Yazd) 2016,14(1),1-8","journal-title":"Int J Reprod Biomed (Yazd)"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.fertnstert.2012.06.023","volume":"98","author":"Jadoul P.","year":"2012","unstructured":"Jadoul P.; Kitajima M.; Donnez O.; Squifflet J.; Donnez J.; Surgical treatment of ovarian endometriomas: state of the art? Fertil Steril 2012,98(3),556-563","journal-title":"Fertil Steril"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"404","DOI":"10.7150\/jca.4956","volume":"3","author":"Kouremenos K.A.","year":"2012","unstructured":"Kouremenos K.A.; Johansson M.; Marriott P.J.; Advances in gas chromatographic methods for the identification of biomarkers in cancer. J Cancer 2012,3,404-420","journal-title":"J Cancer"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1158\/1078-0432.CCR-08-1059","volume":"15","author":"Spratlin J.L.","year":"2009","unstructured":"Spratlin J.L.; Serkova N.J.; Eckhardt S.G.; Clinical applications of metabolomics in oncology: a review. Clin Cancer Res 2009,15(2),431-440","journal-title":"Clin Cancer Res"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S1388-1981(02)00336-0","volume":"1585","author":"Cuvillier O.","year":"2002","unstructured":"Cuvillier O.; Sphingosine in apoptosis signaling. Biochim Biophys Acta 2002,1585(2-3),153-162","journal-title":"Biochim Biophys Acta"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0015-0282(16)56642-4","volume":"61","author":"Sano M.","year":"1994","unstructured":"Sano M.; Morishita T.; Nozaki M.; Yokoyama M.; Watanabe Y.; Nakano H.; Elevation of the phospholipase A2 activity in peritoneal fluid cells from women with endometriosis. Fertil Steril 1994,61(4),657-662","journal-title":"Fertil Steril"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jsbmb.2016.02.023","volume":"159","author":"Vouk K.","year":"2016","unstructured":"Vouk K.; Ribi\u010d-Pucelj M.; Adamski J.; Ri\u017ener T.L.; Altered levels of acylcarnitines, phosphatidylcholines, and sphingomyelins in peritoneal fluid from ovarian endometriosis patients. J Steroid Biochem Mol Biol 2016,159,60-69","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.fertnstert.2016.12.032","volume":"107","author":"Letsiou S.","year":"2017","unstructured":"Letsiou S.; Peterse D.P.; Fassbender A.; Hendriks M.M.; van den Broek N.J.; Berger R.; O D.F.; Vanhie A.; Vodolazkaia A.; Van Langendonckt A.; Donnez J.; Harms A.C.; Vreeken R.J.; Groothuis P.G.; Dolmans M.M.; Brenkman A.B.; D\u2019Hooghe T.M.; Endometriosis is associated with aberrant metabolite profiles in plasma. Fertil Steril 2017,107(3),699-706.e6","journal-title":"Fertil Steril"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1016\/j.fertnstert.2009.08.043","volume":"93","author":"Melo A.S.","year":"2010","unstructured":"Melo A.S.; Rosa-e-Silva J.C.; Rosa-e-Silva A.C.; Poli-Neto O.B.; Ferriani R.A.; Vieira C.S.; Unfavorable lipid profile in women with endometriosis. Fertil Steril 2010,93(7),2433-2436","journal-title":"Fertil Steril"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1039\/C7MB00181A","volume":"13","author":"Marianna S.","year":"2017","unstructured":"Marianna S.; Alessia P.; Susan C.; Francesca C.; Angela S.; Francesca C.; Antonella N.; Patrizia I.; Nicola C.; Emilio C.; Metabolomic profiling and biochemical evaluation of the follicular fluid of endometriosis patients. Mol Biosyst 2017,13(6),1213-1222","journal-title":"Mol Biosyst"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/168768","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T11:37:27Z","timestamp":1603798647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/168768\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,30]]},"references-count":66,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2020,6,30]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867326666190104124245","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,30]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-08-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}